Bioxytran Seeking Partners for Late Stage Treatment of Wuhan Coronavirus Using BXT-25
BXT-25 has the potential to treat late stage acute respiratory distress syndrome (ARDS) which is the leading cause of death in coronavirus patients.
View full press release